http://www.unboundmedicine.com/medline/ebm/research/niacinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19915218/full_citation/Statin_Therapy_with_Ezetimibe_or_Niacin_in_High_Risk_Patients_Kastelein JJ, Bots ML 
Statin Therapy with Ezetimibe or Niacin in High-Risk Patients. [JOURNAL ARTICLE]
N Engl J Med 2009 Nov 15.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19915217/full_citation/Extended_Release_Niacin_or_Ezetimibe_and_Carotid_Intima_Media_Thickness_Taylor AJ, Villines TC, Stanek EJ, et al. 
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness. [JOURNAL ARTICLE]
N Engl J Med 2009 Nov 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19911216/full_citation/Combined_Treatment_with_Dif1stat__R___and_Diet_Reduce_Plasma_Lipid_Indicators_of_Moderate_Hypercholesterolemia_More_Effectively_than_Diet_Alone:_A_Randomized_Trial_in_Parallel_Groups_Stefanutti C, Mazza F, Vivenzio A, et al. 
Combined Treatment with Dif1stat((R)) and Diet Reduce Plasma Lipid Indicators of Moderate Hypercholesterolemia More Effectively than Diet Alone: A Randomized Trial in Parallel Groups. [JOURNAL ARTICLE]
Lipids 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19903187/full_citation/Effects_of_Laropiprant_a_Selective_Prostaglandin_D_Receptor_1_Antagonist_on_the_Pharmacokinetics_of_Rosiglitazone_Schwartz JI, Stroh M, Gao B, et al. 
Effects of Laropiprant, a Selective Prostaglandin D Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone. [JOURNAL ARTICLE]
Cardiovasc Ther 2009 Dec; 27(4):239-245.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19892133/full_citation/Chapter_30_Historical_aspects_of_the_major_neurological_vitamin_deficiency_disorders:_the_water_soluble_B_vitamins_Lanska DJ 
Chapter 30 Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. [Journal Article]
Handb Clin Neurol 2009.:445-76.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19891279/full_citation/Targeting_low_HDL_cholesterol_to_decrease_residual_cardiovascular_risk_in_the_managed_care_setting_Cziraky MJ, Watson KE, Talbert RL 
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. [Journal Article, Research Support, Non-U.S. Gov't]
J Manag Care Pharm 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19084089/full_citation/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_Jones PH 
Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering. [Journal Article]
Am J Cardiol 2008 Dec 22; 102(12A):41L-47L.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19084086/full_citation/A_review_of_the_current_status_of_the_management_of_mixed_dyslipidemia_associated_with_diabetes_mellitus_and_metabolic_syndrome_Davidson M 
A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome. [Journal Article]
Am J Cardiol 2008 Dec 22; 102(12A):19L-27L.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884623/full_citation/Systematic_review:_comparative_effectiveness_and_harms_of_combination_therapy_and_monotherapy_for_dyslipidemia_Sharma M, Ansari MT, Abou-Setta AM, et al. 
Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia. [Journal Article, Research Support, U.S. Gov't, P.H.S.]
Ann Intern Med 2009 Nov 3; 151(9):622-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19878707/full_citation/Niacin_Improves_Renal_Lipid_Metabolism_and_Slows_Progression_in_Chronic_Kidney_Disease_Cho KH, Kim HJ, Kamanna VS, et al. 
Niacin Improves Renal Lipid Metabolism and Slows Progression in Chronic Kidney Disease. [JOURNAL ARTICLE]
Biochim Biophys Acta 2009 Oct 27.
Abstract | Full Citation